We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept


Lesvi's product portfolio comprises CNS pharmaceuticals and nutraceuticals, unique dosage forms and products in other therapeutic areas such as antiemetic, anti-infective, cardiovascular, diseases and pain. 
Product Indication Dosage form Strength
Azithromycin Macrolide antibacterial Film-coated tablets 500 mg
Azithromycin Macrolide antibacterial Powder for oral suspension 200 mg/5 ml
Carmellose - Artificial tears Dry eye Eye drops, solution 2 mg (unit dose)
Ciprofloxacin otic Otitis Ear drops, solution (unit dose) 1 mg
Clopidogrel Atherothrombosis Film-coated tablets 75 mg
Desloratadine Allergy Film-coated tablets 5 mg
Dexketoprofen Analgesic Film-coated tablets 12.5 and 25 mg
Enalapril Hypertension Tablets 5 and 20 mg
Enalapril + HCTZ Hypertension Tablets 20/12.5 mg
Fluconazol Antifungal Hard capsules 50, 100, 150 and 200 mg
Fluconazol Antifungal Powder for oral suspension 200 mg/5ml 
Imidapril * Hypertension Tablets 5, 10 and 20 mg
Ketorolac Analgesic Film-coated tablets 10 mg
Lisinopril Hypertension Tablets 5 and 20 mg
Lisinopril + HCTZ Hypertension Tablets 20/12.5 mg
Loratadine Allergy Film-coated tablets 10 mg
Montelukast Asthma, allergy Chewable tablets 4 and 5 mg
Montelukast Asthma, allergy Film-coated tablets 10 mg
Nabilone * Antiemetic Tablets 1 mg
Ondansetron Nausea & vomiting Film-coated tablets 4 and 8 mg

[*] Differentiated product
[**] Opioid

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.